Manufacturer : MER-MERCK LIMITED
Composition : CETUXIMAB-2MG/ML
Dose Form : INJECTION
Description : ERBITUX 5MG/20ML INJ
Route Of Administration : PARENTERAL
Pack : 1
Erbitux® is an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of: Head and Neck Cancer and Colorectal Cancer.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada.
DOSAGE FORMS AND STRENGTHS
100 mg/50 mL, single-use vial
200 mg/100 mL, single-use vial
Pharma Services and Drug Inquiries
Our Pharma Division deals only with the best, GMP certified generics and branded medication for the export market. All our products are supported by strict adherence to quality and analysis certification.
Please note for the minimum order for Exports is of US$ 300. All orders will be subject to courier charges and supplies are normally dispatched through internationally accredited courier services.
Complete the form below to receive the no-obligation price quote.
Note : We do not supply schedule-H (Example – narcotic drug or psychotropic drugs or anabolic steroids) and Anti- Abortion Drugs.